Amerise Biosciences intimated BSE of its upcoming board meeting scheduled for May 5, 2026.
The board will consider approval of audited standalone financial results for Q4 and FY ending March 31, 2026.
The disclosure is made pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015.